Skip to main navigation Skip to search Skip to main content

A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of AG-120 in Combination with Azacitidine in Subjects >or= 18 Years of Age with Previously Untreated Acute Myeloid Leukemia with an IDHI Mutation

Project: Research

Project Details

StatusFinished
Effective start/end date08/18/17 → 06/25/19

Funding

  • Agios Pharmaceuticals Incorporated: $22,317.51